Boston Scientific BSX is slated to report fourth ... the company is likely to have registered balanced growth across the Vercise Genus portfolio and the innovative Image Guided Programming ...

The stock's fall snapped a two-day winning streak.

Boston Scientific (NYSE: BSX) announced today that it agreed to acquire intravascular ultrasound system developer SoniVie.

Boston Scientific has led a $175 million funding round for the mitral valve developer 4C Medical, which is currently working ...

Marlborough medical device manufacturer Boston Scientific has entered into a purchase agreement worth up to half a billion ...

Shares of Boston Scientific Corp. BSX slipped 1.66% to $99.13 Friday, on what proved to be an all-around great trading ...

C Medical Technologies announced today that it closed a Series D financing round resulting in gross proceeds of up to $175 ...

Boston Scientific’s BSX fourth-quarter 2024 performance was driven by its robust expansion of operations across different geographies outside the United States. The company’s impressive strategic ...

Boston Scientific has gained a duo of CE markings in the European Union (EU) for its navigation enabled Farawave NAV Ablation Catheter for paroxysmal atrial fibrillation (AF) treatment and its new ...

(RTTNews) - Boston Scientific Corp. (BSX), Monday announced its decision to acquire SoniVie Ltd., a privately held medical device company that has developed the TIVUS Intravascular Ultrasound System.